Bupropion-Induced Severe Leukocytosis
- PMID: 33224676
- PMCID: PMC7678766
- DOI: 10.7759/cureus.11083
Bupropion-Induced Severe Leukocytosis
Abstract
Bupropion hydrochloride is a norepinephrine-dopamine reuptake inhibitor approved for the treatment of depression and smoking cessation. Although cardiovascular and hematological side effects are common with bupropion along with weight loss and headache, hematological side effects are rarely reported other than few post marketing studies. Here we present the case of a 47-year-old white female who presented with significant leukocytosis after bupropion overdose.
Keywords: anti depressant; bupropion; emergency; hematology; leukocytosis; overdose.
Copyright © 2020, Jolly et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Inflammatory markers associated with seizures. Sohn HS, Kim SK, Lee SY. Epileptic Disord. 2016;18:51–57. - PubMed
-
- Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. Wilens TE, Hammerness PG, Biederman J, et al. https://www.researchgate.net/profile/Matthew_Morris/publication/8027983_.... J Clin Psychiatry. 2005;66:253–259. - PubMed
-
- FDA: prescribing information. [Sep;2020 ];https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021515s023s024... 2020
-
- Evaluation of patients with leukocytosis. Riley LK, Rupert J. https://www.aafp.org/afp/2015/1201/p1004.html. Am Fam Physician. 2015;92:1004–1011. - PubMed
-
- Why does my patient have leukocytosis? Cerny J, Rosmarin AG. Hematol Oncol Clin North Am. 2012;26:303–319. - PubMed
Publication types
LinkOut - more resources
Full Text Sources